LOCUS       VAV_HUMAN                845 aa            linear   PRI 03-AUG-2022
DEFINITION  RecName: Full=Proto-oncogene vav.
ACCESSION   P15498
VERSION     P15498.4
DBSOURCE    UniProtKB: locus VAV_HUMAN, accession P15498;
            class: standard.
            extra accessions:B4DVK9,M0QXX6,Q15860
            created: Apr 1, 1990.
            sequence updated: Feb 21, 2001.
            annotation updated: Aug 3, 2022.
            xrefs: AF030227.1, AAC25011.1, AF030201.1, AF030202.1, AF030203.1,
            AF030204.1, AF030205.1, AF030206.1, AF030207.1, AF030208.1,
            AF030209.1, AF030210.1, AF030211.1, AF030212.1, AF030213.1,
            AF030214.1, AF030215.1, AF030216.1, AF030217.1, AF030218.1,
            AF030219.1, AF030220.1, AF030221.1, AF030222.1, AF030223.1,
            AF030224.1, AF030225.1, AF030226.1, AC010647.5, AC020895.8,
            AC020954.8, AC022156.8, M59834.1, AAA63267.1, AK301128.1,
            BAG62721.1, X16316.1, CAA34383.1, X83931.1, CAA58783.1, TVHUVV,
            NP_001245136.1, NP_005419.2, 2CRH_A, 2LCT_A, 2MC1_A, 2ROR_A,
            3BJI_A, 3BJI_B, 3KY9_A, 3KY9_B, 6NEW_A, 6NF1_A, 6NFA_A
            xrefs (non-sequence databases): CCDS:CCDS12174.1, CCDS:CCDS59342.1,
            PDBsum:2CRH, PDBsum:2LCT, PDBsum:2MC1, PDBsum:2ROR, PDBsum:3BJI,
            PDBsum:3KY9, PDBsum:6NEW, PDBsum:6NF1, PDBsum:6NFA,
            AlphaFoldDB:P15498, BMRB:P15498, SMR:P15498, BioGRID:113252,
            CORUM:P15498, DIP:DIP-1061N, IntAct:P15498, MINT:P15498,
            STRING:9606.ENSP00000472929, BindingDB:P15498,
            ChEMBL:CHEMBL3259472, iPTMnet:P15498, PhosphoSitePlus:P15498,
            BioMuta:VAV1, DMDM:13124807, CPTAC:CPTAC-1226, CPTAC:CPTAC-1227,
            EPD:P15498, jPOST:P15498, MassIVE:P15498, MaxQB:P15498,
            PaxDb:P15498, PeptideAtlas:P15498, PRIDE:P15498,
            ProteomicsDB:53143, Antibodypedia:665, DNASU:7409,
            Ensembl:ENST00000596764.5, Ensembl:ENSP00000469450.1,
            Ensembl:ENSG00000141968.8, Ensembl:ENST00000602142.6,
            Ensembl:ENSP00000472929.1, GeneID:7409, KEGG:hsa:7409,
            MANE-Select:ENST00000602142.6, UCSC:uc002mfu.3, CTD:7409,
            DisGeNET:7409, GeneCards:VAV1, HGNC:12657, HPA:ENSG00000141968, MIM
            164875, neXtProt:NX_P15498, OpenTargets:ENSG00000141968,
            PharmGKB:PA37280, VEuPathDB:HostDB:ENSG00000141968, eggNOG:KOG2996,
            GeneTree:ENSGT00940000159125, InParanoid:P15498, OMA:PYISRPT,
            PhylomeDB:P15498, TreeFam:TF316171, PathwayCommons:P15498,
            Reactome:R-HSA-114604, Reactome:R-HSA-1257604,
            Reactome:R-HSA-1433557, Reactome:R-HSA-193648,
            Reactome:R-HSA-2029482, Reactome:R-HSA-2219530,
            Reactome:R-HSA-2871796, Reactome:R-HSA-2871809,
            Reactome:R-HSA-389359, Reactome:R-HSA-416482,
            Reactome:R-HSA-4420097, Reactome:R-HSA-512988,
            Reactome:R-HSA-5218920, Reactome:R-HSA-6811558,
            Reactome:R-HSA-8980692, Reactome:R-HSA-9013149,
            Reactome:R-HSA-9013404, Reactome:R-HSA-9013408,
            Reactome:R-HSA-9027284, Reactome:R-HSA-912631,
            Reactome:R-HSA-9664422, Reactome:R-HSA-9748787,
            Reactome:R-HSA-983695, SignaLink:P15498, SIGNOR:P15498,
            BioGRID-ORCS:7409, ChiTaRS:VAV1, EvolutionaryTrace:P15498,
            GenomeRNAi:7409, Pharos:P15498, PRO:PR:P15498,
            Proteomes:UP000005640, RNAct:P15498, Bgee:ENSG00000141968,
            ExpressionAtlas:P15498, Genevisible:P15498, GO:0005911, GO:0005737,
            GO:0005829, GO:0005886, GO:0005085, GO:0046872, GO:0140031,
            GO:0001784, GO:0016477, GO:0071466, GO:0038095, GO:0038096,
            GO:0007186, GO:0006955, GO:0007229, GO:0030593, GO:0030168,
            GO:0043547, GO:0045954, GO:0072593, GO:0008361, GO:0043087,
            GO:0051056, GO:0007264, GO:0031295, GO:0030217, GO:0048010,
            CDD:cd00029, CDD:cd01223, CDD:cd00160, CDD:cd10405, CDD:cd11979,
            CDD:cd11976, Gene3D:1.10.418.10, Gene3D:1.20.900.10,
            Gene3D:2.30.29.30, Gene3D:3.30.505.10, IDEAL:IID00652,
            InterPro:IPR022613, InterPro:IPR001715, InterPro:IPR036872,
            InterPro:IPR035899, InterPro:IPR000219, InterPro:IPR001331,
            InterPro:IPR002219, InterPro:IPR011993, InterPro:IPR001849,
            InterPro:IPR037832, InterPro:IPR000980, InterPro:IPR036860,
            InterPro:IPR036028, InterPro:IPR001452, InterPro:IPR003096,
            InterPro:IPR028530, InterPro:IPR035879, InterPro:IPR035730,
            InterPro:IPR035729, PANTHER:PTHR45818:SF2, Pfam:PF00130,
            Pfam:PF11971, Pfam:PF00169, Pfam:PF00621, Pfam:PF00017,
            Pfam:PF00018, PRINTS:PR00401, PRINTS:PR00452, PRINTS:PR00888,
            SMART:SM00109, SMART:SM00033, SMART:SM00233, SMART:SM00325,
            SMART:SM00252, SMART:SM00326, SUPFAM:SSF47576, SUPFAM:SSF48065,
            SUPFAM:SSF50044, SUPFAM:SSF55550, PROSITE:PS50021, PROSITE:PS00741,
            PROSITE:PS50010, PROSITE:PS50003, PROSITE:PS50001, PROSITE:PS50002,
            PROSITE:PS00479, PROSITE:PS50081
KEYWORDS    3D-structure; Alternative splicing; Guanine-nucleotide releasing
            factor; Metal-binding; Phosphoprotein; Proto-oncogene; Reference
            proteome; Repeat; SH2 domain; SH3 domain; Zinc; Zinc-finger.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (residues 1 to 845)
  AUTHORS   Coppola,J., Bryant,S., Koda,T., Conway,D. and Barbacid,M.
  TITLE     Mechanism of activation of the vav protooncogene
  JOURNAL   Cell Growth Differ 2 (2), 95-105 (1991)
   PUBMED   2069873
  REMARK    NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND MUTAGENESIS OF CYS-529.
REFERENCE   2  (residues 1 to 845)
  AUTHORS   Denkinger,D.J., Borges,C.R., Butler,C.L., Cushman,A.M. and
            Kawahara,R.S.
  TITLE     Genomic organization and regulation of the vav proto-oncogene
  JOURNAL   Biochim Biophys Acta 1491 (1-3), 253-262 (2000)
   PUBMED   10760587
  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA].
REFERENCE   3  (residues 1 to 845)
  AUTHORS   Grimwood,J., Gordon,L.A., Olsen,A., Terry,A., Schmutz,J.,
            Lamerdin,J., Hellsten,U., Goodstein,D., Couronne,O.,
            Tran-Gyamfi,M., Aerts,A., Altherr,M., Ashworth,L., Bajorek,E.,
            Black,S., Branscomb,E., Caenepeel,S., Carrano,A., Caoile,C.,
            Chan,Y.M., Christensen,M., Cleland,C.A., Copeland,A., Dalin,E.,
            Dehal,P., Denys,M., Detter,J.C., Escobar,J., Flowers,D.,
            Fotopulos,D., Garcia,C., Georgescu,A.M., Glavina,T., Gomez,M.,
            Gonzales,E., Groza,M., Hammon,N., Hawkins,T., Haydu,L., Ho,I.,
            Huang,W., Israni,S., Jett,J., Kadner,K., Kimball,H., Kobayashi,A.,
            Larionov,V., Leem,S.H., Lopez,F., Lou,Y., Lowry,S., Malfatti,S.,
            Martinez,D., McCready,P., Medina,C., Morgan,J., Nelson,K.,
            Nolan,M., Ovcharenko,I., Pitluck,S., Pollard,M., Popkie,A.P.,
            Predki,P., Quan,G., Ramirez,L., Rash,S., Retterer,J., Rodriguez,A.,
            Rogers,S., Salamov,A., Salazar,A., She,X., Smith,D., Slezak,T.,
            Solovyev,V., Thayer,N., Tice,H., Tsai,M., Ustaszewska,A., Vo,N.,
            Wagner,M., Wheeler,J., Wu,K., Xie,G., Yang,J., Dubchak,I.,
            Furey,T.S., DeJong,P., Dickson,M., Gordon,D., Eichler,E.E.,
            Pennacchio,L.A., Richardson,P., Stubbs,L., Rokhsar,D.S.,
            Myers,R.M., Rubin,E.M. and Lucas,S.M.
  TITLE     The DNA sequence and biology of human chromosome 19
  JOURNAL   Nature 428 (6982), 529-535 (2004)
   PUBMED   15057824
  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
REFERENCE   4  (residues 1 to 845)
  AUTHORS   Katzav,S., Cleveland,J.L., Heslop,H.E. and Pulido,D.
  TITLE     Loss of the amino-terminal helix-loop-helix domain of the vav
            proto-oncogene activates its transforming potential
  JOURNAL   Mol Cell Biol 11 (4), 1912-1920 (1991)
   PUBMED   2005887
  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-61.
REFERENCE   5  (residues 1 to 845)
  AUTHORS   Ota,T., Suzuki,Y., Nishikawa,T., Otsuki,T., Sugiyama,T., Irie,R.,
            Wakamatsu,A., Hayashi,K., Sato,H., Nagai,K., Kimura,K., Makita,H.,
            Sekine,M., Obayashi,M., Nishi,T., Shibahara,T., Tanaka,T.,
            Ishii,S., Yamamoto,J., Saito,K., Kawai,Y., Isono,Y., Nakamura,Y.,
            Nagahari,K., Murakami,K., Yasuda,T., Iwayanagi,T., Wagatsuma,M.,
            Shiratori,A., Sudo,H., Hosoiri,T., Kaku,Y., Kodaira,H., Kondo,H.,
            Sugawara,M., Takahashi,M., Kanda,K., Yokoi,T., Furuya,T.,
            Kikkawa,E., Omura,Y., Abe,K., Kamihara,K., Katsuta,N., Sato,K.,
            Tanikawa,M., Yamazaki,M., Ninomiya,K., Ishibashi,T., Yamashita,H.,
            Murakawa,K., Fujimori,K., Tanai,H., Kimata,M., Watanabe,M.,
            Hiraoka,S., Chiba,Y., Ishida,S., Ono,Y., Takiguchi,S., Watanabe,S.,
            Yosida,M., Hotuta,T., Kusano,J., Kanehori,K., Takahashi-Fujii,A.,
            Hara,H., Tanase,T.O., Nomura,Y., Togiya,S., Komai,F., Hara,R.,
            Takeuchi,K., Arita,M., Imose,N., Musashino,K., Yuuki,H., Oshima,A.,
            Sasaki,N., Aotsuka,S., Yoshikawa,Y., Matsunawa,H., Ichihara,T.,
            Shiohata,N., Sano,S., Moriya,S., Momiyama,H., Satoh,N., Takami,S.,
            Terashima,Y., Suzuki,O., Nakagawa,S., Senoh,A., Mizoguchi,H.,
            Goto,Y., Shimizu,F., Wakebe,H., Hishigaki,H., Watanabe,T.,
            Sugiyama,A., Takemoto,M., Kawakami,B., Yamazaki,M., Watanabe,K.,
            Kumagai,A., Itakura,S., Fukuzumi,Y., Fujimori,Y., Komiyama,M.,
            Tashiro,H., Tanigami,A., Fujiwara,T., Ono,T., Yamada,K., Fujii,Y.,
            Ozaki,K., Hirao,M., Ohmori,Y., Kawabata,A., Hikiji,T., Kobatake,N.,
            Inagaki,H., Ikema,Y., Okamoto,S., Okitani,R., Kawakami,T.,
            Noguchi,S., Itoh,T., Shigeta,K., Senba,T., Matsumura,K.,
            Nakajima,Y., Mizuno,T., Morinaga,M., Sasaki,M., Togashi,T.,
            Oyama,M., Hata,H., Watanabe,M., Komatsu,T., Mizushima-Sugano,J.,
            Satoh,T., Shirai,Y., Takahashi,Y., Nakagawa,K., Okumura,K.,
            Nagase,T., Nomura,N., Kikuchi,H., Masuho,Y., Yamashita,R.,
            Nakai,K., Yada,T., Nakamura,Y., Ohara,O., Isogai,T. and Sugano,S.
  TITLE     Complete sequencing and characterization of 21,243 full-length
            human cDNAs
  JOURNAL   Nat Genet 36 (1), 40-45 (2004)
   PUBMED   14702039
  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 51-813 (ISOFORM 2).;
            TISSUE=Spleen
REFERENCE   6  (residues 1 to 845)
  AUTHORS   Katzav,S., Martin-Zanca,D. and Barbacid,M.
  TITLE     vav, a novel human oncogene derived from a locus ubiquitously
            expressed in hematopoietic cells
  JOURNAL   EMBO J 8 (8), 2283-2290 (1989)
   PUBMED   2477241
  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 68-845 (ISOFORM 1).
REFERENCE   7  (residues 1 to 845)
  AUTHORS   Romero,F.
  TITLE     Direct Submission
  JOURNAL   Submitted (??-JAN-1995) to the EMBL/GenBank/DDBJ databases
  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 299-837 (ISOFORM 1).
REFERENCE   8  (residues 1 to 845)
  AUTHORS   Ramos-Morales,F., Romero,F., Schweighoffer,F., Bismuth,G.,
            Camonis,J., Tortolero,M. and Fischer,S.
  TITLE     The proline-rich region of Vav binds to Grb2 and Grb3-3
  JOURNAL   Oncogene 11 (8), 1665-1669 (1995)
   PUBMED   7478592
  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 299-334 (ISOFORM 1).
REFERENCE   9  (residues 1 to 845)
  AUTHORS   Adams,J.M., Houston,H., Allen,J., Lints,T. and Harvey,R.
  TITLE     The hematopoietically expressed vav proto-oncogene shares homology
            with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene
            (CDC24) involved in cytoskeletal organization
  JOURNAL   Oncogene 7 (4), 611-618 (1992)
   PUBMED   1565462
  REMARK    SIMILARITY TO CDC24 FAMILY.
REFERENCE   10 (residues 1 to 845)
  AUTHORS   Deckert,M., Tartare-Deckert,S., Couture,C., Mustelin,T. and
            Altman,A.
  TITLE     Functional and physical interactions of Syk family kinases with the
            Vav proto-oncogene product
  JOURNAL   Immunity 5 (6), 591-604 (1996)
   PUBMED   8986718
  REMARK    INTERACTION WITH SYK, AND MUTAGENESIS OF ARG-696.
REFERENCE   11 (residues 1 to 845)
  AUTHORS   Bustelo,X.R., Crespo,P., Lopez-Barahona,M., Gutkind,J.S. and
            Barbacid,M.
  TITLE     Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits
            Vav-mediated c-Jun N-terminal kinase activation
  JOURNAL   Oncogene 15 (21), 2511-2520 (1997)
   PUBMED   9399639
  REMARK    INTERACTION WITH CBLB.
REFERENCE   12 (residues 1 to 845)
  AUTHORS   Fu,C., Turck,C.W., Kurosaki,T. and Chan,A.C.
  TITLE     BLNK: a central linker protein in B cell activation
  JOURNAL   Immunity 9 (1), 93-103 (1998)
   PUBMED   9697839
  REMARK    INTERACTION WITH BLNK; PLCG1; GRB2 AND NCK1.
REFERENCE   13 (residues 1 to 845)
  AUTHORS   Germani,A., Romero,F., Houlard,M., Camonis,J., Gisselbrecht,S.,
            Fischer,S. and Varin-Blank,N.
  TITLE     hSiah2 is a new Vav binding protein which inhibits Vav-mediated
            signaling pathways
  JOURNAL   Mol Cell Biol 19 (5), 3798-3807 (1999)
   PUBMED   10207103
  REMARK    INTERACTION WITH SIAH2.
REFERENCE   14 (residues 1 to 845)
  AUTHORS   Huang,J., Tilly,D., Altman,A., Sugie,K. and Grey,H.M.
  TITLE     T-cell receptor antagonists induce Vav phosphorylation by selective
            activation of Fyn kinase
  JOURNAL   Proc Natl Acad Sci U S A 97 (20), 10923-10929 (2000)
   PUBMED   11005864
  REMARK    PHOSPHORYLATION BY FYN.
REFERENCE   15 (residues 1 to 845)
  AUTHORS   Nishihara,H., Maeda,M., Oda,A., Tsuda,M., Sawa,H., Nagashima,K. and
            Tanaka,S.
  TITLE     DOCK2 associates with CrkL and regulates Rac1 in human leukemia
            cell lines
  JOURNAL   Blood 100 (12), 3968-3974 (2002)
   PUBMED   12393632
  REMARK    INTERACTION WITH DOCK2.
REFERENCE   16 (residues 1 to 845)
  AUTHORS   Lindholm,C.K., Henriksson,M.L., Hallberg,B. and Welsh,M.
  TITLE     Shb links SLP-76 and Vav with the CD3 complex in Jurkat T cells
  JOURNAL   Eur J Biochem 269 (13), 3279-3288 (2002)
   PUBMED   12084069
  REMARK    INTERACTION WITH SHB.
REFERENCE   17 (residues 1 to 845)
  AUTHORS   Yabana,N. and Shibuya,M.
  TITLE     Adaptor protein APS binds the NH2-terminal autoinhibitory domain of
            guanine nucleotide exchange factor Vav3 and augments its activity
  JOURNAL   Oncogene 21 (50), 7720-7729 (2002)
   PUBMED   12400014
  REMARK    INTERACTION WITH SH2B2.
REFERENCE   18 (residues 1 to 845)
  AUTHORS   Dombroski,D., Houghtling,R.A., Labno,C.M., Precht,P., Takesono,A.,
            Caplen,N.J., Billadeau,D.D., Wange,R.L., Burkhardt,J.K. and
            Schwartzberg,P.L.
  TITLE     Kinase-independent functions for Itk in TCR-induced regulation of
            Vav and the actin cytoskeleton
  JOURNAL   J Immunol 174 (3), 1385-1392 (2005)
   PUBMED   15661896
  REMARK    INTERACTION WITH ITK.
REFERENCE   19 (residues 1 to 845)
  AUTHORS   Miller,S.L., DeMaria,J.E., Freier,D.O., Riegel,A.M. and
            Clevenger,C.V.
  TITLE     Novel association of Vav2 and Nek3 modulates signaling through the
            human prolactin receptor
  JOURNAL   Mol Endocrinol 19 (4), 939-949 (2005)
   PUBMED   15618286
  REMARK    INTERACTION WITH NEK3.
REFERENCE   20 (residues 1 to 845)
  AUTHORS   Rush,J., Moritz,A., Lee,K.A., Guo,A., Goss,V.L., Spek,E.J.,
            Zhang,H., Zha,X.M., Polakiewicz,R.D. and Comb,M.J.
  TITLE     Immunoaffinity profiling of tyrosine phosphorylation in cancer
            cells
  JOURNAL   Nat Biotechnol 23 (1), 94-101 (2005)
   PUBMED   15592455
  REMARK    PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-826, AND
            IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
REFERENCE   21 (residues 1 to 845)
  AUTHORS   Houlard,M., Romero-Portillo,F., Germani,A., Depaux,A.,
            Regnier-Ricard,F., Gisselbrecht,S. and Varin-Blank,N.
  TITLE     Characterization of VIK-1: a new Vav-interacting Kruppel-like
            protein
  JOURNAL   Oncogene 24 (1), 28-38 (2005)
   PUBMED   15558030
  REMARK    INTERACTION WITH ZNF655/VIK.
REFERENCE   22 (residues 1 to 845)
  AUTHORS   Gao,C. and Blystone,S.D.
  TITLE     A Pyk2-Vav1 complex is recruited to beta3-adhesion sites to
            initiate Rho activation
  JOURNAL   Biochem J 420 (1), 49-56 (2009)
   PUBMED   19207108
  REMARK    INTERACTION WITH PTK2B/PYK2.
            Publication Status: Online-Only
REFERENCE   23 (residues 1 to 845)
  AUTHORS   Burkard,T.R., Planyavsky,M., Kaupe,I., Breitwieser,F.P.,
            Burckstummer,T., Bennett,K.L., Superti-Furga,G. and Colinge,J.
  TITLE     Initial characterization of the human central proteome
  JOURNAL   BMC Syst Biol 5, 17 (2011)
   PUBMED   21269460
  REMARK    IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
            Publication Status: Online-Only
REFERENCE   24 (residues 1 to 845)
  AUTHORS   Srikanth,S., Kim,K.D., Gao,Y., Woo,J.S., Ghosh,S., Calmettes,G.,
            Paz,A., Abramson,J., Jiang,M. and Gwack,Y.
  TITLE     A large Rab GTPase encoded by CRACR2A is a component of subsynaptic
            vesicles that transmit T cell activation signals
  JOURNAL   Sci Signal 9 (420), ra31 (2016)
   PUBMED   27016526
  REMARK    INTERACTION WITH CRACR2A.
            Publication Status: Online-Only
REFERENCE   25 (residues 1 to 845)
  CONSRTM   RIKEN structural genomics initiative (RSGI)
  TITLE     Direct Submission
  JOURNAL   Submitted (??-NOV-2005) to the PDB data bank
  REMARK    STRUCTURE BY NMR OF 661-775.
COMMENT     On or before Apr 6, 2005 this sequence version replaced gi:2144604,
            gi:586213.
            [FUNCTION] Couples tyrosine kinase signals with the activation of
            the Rho/Rac GTPases, thus leading to cell differentiation and/or
            proliferation.
            [SUBUNIT] Interacts with SHB (PubMed:12084069). Interacts with
            SH2B2, GRB2, GRB3, DOCK2, SLA, TEC and ZNF655/VIK (PubMed:12393632,
            PubMed:12400014, PubMed:15558030). Interacts with SIAH2; without
            leading to its degradation (PubMed:10207103). Associates with BLNK,
            PLCG1, GRB2 and NCK1 in a B-cell antigen receptor-dependent fashion
            (PubMed:9697839). Interacts with CBLB; which inhibits tyrosine
            phosphorylation and down-regulates activity (PubMed:9399639). May
            interact with CCPG1. Interacts with CLNK. Interacts with THEMIS2
            (By similarity). Interacts with NEK3 and this interaction is
            prolactin-dependent (PubMed:15618286). Interacts with ITK
            (PubMed:15661896). Interacts with PTK2B/PYK2 (By similarity).
            Interacts with HCK. Interacts with PTK2B/PYK2 (PubMed:19207108).
            Interacts (via SH2 domain) with SYK (PubMed:8986718). Interacts
            with ANKRD54. Interacts with CD6 (By similarity). Interacts with
            isoform 2 of CRACR2A (PubMed:27016526).
            {ECO:0000250|UniProtKB:P27870, ECO:0000269|PubMed:10207103,
            ECO:0000269|PubMed:12084069, ECO:0000269|PubMed:12393632,
            ECO:0000269|PubMed:12400014, ECO:0000269|PubMed:15558030,
            ECO:0000269|PubMed:15618286, ECO:0000269|PubMed:15661896,
            ECO:0000269|PubMed:19207108, ECO:0000269|PubMed:27016526,
            ECO:0000269|PubMed:8986718, ECO:0000269|PubMed:9399639,
            ECO:0000269|PubMed:9697839}.
            [INTERACTION] P15498; Q8IZP0: ABI1; NbExp=2; IntAct=EBI-625518,
            EBI-375446; P15498; P00519: ABL1; NbExp=5; IntAct=EBI-625518,
            EBI-375543; P15498; Q13480: GAB1; NbExp=2; IntAct=EBI-625518,
            EBI-517684; P15498; P62993: GRB2; NbExp=3; IntAct=EBI-625518,
            EBI-401755; P15498; Q07666: KHDRBS1; NbExp=3; IntAct=EBI-625518,
            EBI-1364; P15498; Q13094: LCP2; NbExp=9; IntAct=EBI-625518,
            EBI-346946; P15498; P63000: RAC1; NbExp=2; IntAct=EBI-625518,
            EBI-413628; P15498; P78314: SH3BP2; NbExp=8; IntAct=EBI-625518,
            EBI-727062; P15498; Q8N720: ZNF655; NbExp=5; IntAct=EBI-625518,
            EBI-625509; P15498; P08487: PLCG1; Xeno; NbExp=4;
            IntAct=EBI-625518, EBI-8013886.
            [ALTERNATIVE PRODUCTS] Event=Alternative splicing; Named
            isoforms=2; Name=1; IsoId=P15498-1; Sequence=Displayed; Name=2;
            IsoId=P15498-2; Sequence=VSP_047563.
            [TISSUE SPECIFICITY] Widely expressed in hematopoietic cells but
            not in other cell types.
            [DOMAIN] The DH domain is involved in interaction with CCPG1.
            {ECO:0000250}.
            [PTM] Phosphorylated on tyrosine residues by HCK in response to
            IFNG and bacterial lipopolysaccharide (LPS) (By similarity).
            Phosphorylated by FYN. {ECO:0000250, ECO:0000269|PubMed:11005864}.
            [MISCELLANEOUS] 'Vav' stands for the sixth letter of the Hebrew
            alphabet.
            [SEQUENCE CAUTION] Sequence=BAG62721.1; Type=Erroneous initiation;
            Note=Truncated N-terminus.; Evidence={ECO:0000305};
            Sequence=CAA34383.1; Type=Frameshift; Evidence={ECO:0000305}.
            [WEB RESOURCE] Name=Atlas of Genetics and Cytogenetics in Oncology
            and Haematology;
            URL='http://atlasgeneticsoncology.org/Genes/VAV1ID195ch19p13.html'.
FEATURES             Location/Qualifiers
     source          1..845
                     /organism="Homo sapiens"
                     /db_xref="taxon:9606"
     gene            1..845
                     /gene="VAV1"
                     /gene_synonym="VAV"
     Protein         1..845
                     /product="Proto-oncogene vav"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..845
                     /region_name="Mature chain"
                     /note="Proto-oncogene vav. /id=PRO_0000080980."
     Region          1..119
                     /region_name="Domain"
                     /note="Calponin-homology (CH).
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU00044."
     Region          2..121
                     /region_name="CH_VAV1"
                     /note="calponin homology (CH) domain found in VAV1
                     protein; cd21262"
                     /db_xref="CDD:409111"
     Site            order(3,7,70,72..73,76..77,79,90..98,104,106..107,
                     109..110,113..114,117)
                     /site_type="other"
                     /note="putative actin binding site [polypeptide binding]"
                     /db_xref="CDD:409111"
     Region          3..13
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NF1."
     Region          22..24
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:6NF1."
     Region          30..37
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NF1."
     Region          41..50
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NF1."
     Region          57..59
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NF1."
     Region          68..84
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NF1."
     Region          90..92
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:6NF1."
     Region          96..100
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NF1."
     Region          105..116
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NF1."
     Region          119..122
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NF1."
     Region          123..125
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:6NF1."
     Region          145..148
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NF1."
     Region          158..160
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NF1."
     Region          173..177
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          187..218
                     /region_name="Splicing variant"
                     /note="Missing (in isoform 2).
                     /evidence=ECO:0000303|PubMed:14702039. /id=VSP_047563."
     Region          191..219
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          194..373
                     /region_name="Domain"
                     /note="DH.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU00062."
     Region          195..371
                     /region_name="RhoGEF"
                     /note="Guanine nucleotide exchange factor for
                     Rho/Rac/Cdc42-like GTPases; Also called Dbl-homologous
                     (DH) domain. It appears that PH domains invariably occur
                     C-terminal to RhoGEF/DH domains; cd00160"
                     /db_xref="CDD:238091"
     Site            order(201,205,295,323..324,327..328,330..331,334..335,
                     338..339,342,367,371)
                     /site_type="other"
                     /note="GTPase interaction site [polypeptide binding]"
                     /db_xref="CDD:238091"
     Region          221..225
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          230..236
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          240..259
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          261..263
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          264
                     /region_name="Conflict"
                     /note="A -> P (in Ref. 6; CAA34383).
                     /evidence=ECO:0000305."
     Region          266..273
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          276..278
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          279..285
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          287..300
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          302..316
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          317..319
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:6NF1."
     Region          322..325
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          328..333
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          336..345
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          350..389
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          368
                     /region_name="Conflict"
                     /note="Q -> R (in Ref. 5; BAG62721).
                     /evidence=ECO:0000305."
     Region          385..508
                     /region_name="PH_Vav"
                     /note="Vav pleckstrin homology (PH) domain; cd01223"
                     /db_xref="CDD:269930"
     Region          390..392
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          397..400
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          402..504
                     /region_name="Domain"
                     /note="PH.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU00145."
     Region          403..412
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          420..437
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          440..448
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          449..451
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          452..456
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          458..460
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          461..463
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          469..475
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          481..488
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          489..506
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          509..512
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          510..566
                     /region_name="C1_VAV1"
                     /note="protein kinase C conserved region 1 (C1 domain)
                     found in VAV1 protein; cd20867"
                     /db_xref="CDD:410417"
     Region          513..515
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          515..564
                     /region_name="Zinc finger region"
                     /note="Phorbol-ester/DAG-type.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU00226."
     Site            order(516,529,532,546,549,554,557,564)
                     /site_type="other"
                     /note="Zn binding site [ion binding]"
                     /db_xref="CDD:410417"
     Region          518..521
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Site            529
                     /site_type="mutagenized"
                     /note="C->R: Abolishes transforming activity.
                     /evidence=ECO:0000269|PubMed:2069873."
     Region          530..532
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          538..540
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          543..546
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          547..549
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          555..560
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6NEW."
     Region          592..660
                     /region_name="Domain"
                     /note="SH3 1.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU00192."
     Region          596..658
                     /region_name="SH3_VAV1_1"
                     /note="First Src homology 3 domain of VAV1 protein;
                     cd11979"
                     /db_xref="CDD:212912"
     Site            order(601,603,606,616,635..636,651,653..654)
                     /site_type="other"
                     /note="peptide ligand binding site [polypeptide binding]"
                     /db_xref="CDD:212912"
     Region          665..767
                     /region_name="SH2_Vav1"
                     /note="Src homology 2 (SH2) domain found in the Vav1
                     proteins; cd10405"
                     /db_xref="CDD:198268"
     Region          666..668
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:2CRH."
     Region          669..672
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:2CRH."
     Region          671..765
                     /region_name="Domain"
                     /note="SH2.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU00191."
     Site            order(678,696,717,719)
                     /site_type="other"
                     /note="phosphotyrosine binding pocket [polypeptide
                     binding]"
                     /db_xref="CDD:198268"
     Region          678..684
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:2CRH."
     Region          685..687
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:2CRH."
     Region          692..696
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:2CRH."
     Site            696
                     /site_type="mutagenized"
                     /note="R->L: Loss of interaction with SYK.
                     /evidence=ECO:0000269|PubMed:8986718."
     Region          700..702
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:2LCT."
     Region          706..711
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:2CRH."
     Region          714..719
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:2CRH."
     Site            order(718,745)
                     /site_type="other"
                     /note="hydrophobic binding pocket [polypeptide binding]"
                     /db_xref="CDD:198268"
     Region          718
                     /region_name="Conflict"
                     /note="I -> TV (in Ref. 6). /evidence=ECO:0000305."
     Region          721..723
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:2CRH."
     Region          726..730
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:2CRH."
     Region          735..737
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:2CRH."
     Region          738..745
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:2CRH."
     Region          739
                     /region_name="Variant"
                     /note="T -> M (in dbSNP:rs36097961). /id=VAR_051997."
     Region          750..752
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:2CRH."
     Region          754..756
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:2LCT."
     Region          763..766
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:2CRH."
     Region          782..842
                     /region_name="Domain"
                     /note="SH3 2.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU00192."
     Region          786..839
                     /region_name="SH3_VAV1_2"
                     /note="C-terminal (or second) Src homology 3 domain of
                     VAV1 protein; cd11976"
                     /db_xref="CDD:212909"
     Site            order(791,793,796,800,819..820,833,835..836)
                     /site_type="other"
                     /note="peptide ligand binding site [polypeptide binding]"
                     /db_xref="CDD:212909"
     Site            826
                     /site_type="phosphorylation"
                     /note="Phosphotyrosine.
                     /evidence=ECO:0007744|PubMed:15592455."
     Site            844
                     /site_type="phosphorylation"
                     /note="Phosphotyrosine.
                     /evidence=ECO:0000250|UniProtKB:P27870."
ORIGIN      
        1 melwrqcthw liqcrvlpps hrvtwdgaqv celaqalrdg vllcqllnnl lphainlrev
       61 nlrpqmsqfl clknirtfls tccekfglkr selfeafdlf dvqdfgkviy tlsalswtpi
      121 aqnrgimpfp teeesvgded iysglsdqid dtveededly dcveneeaeg deiyedlmrs
      181 epvsmppkmt eydkrccclr eiqqteekyt dtlgsiqqhf lkplqrflkp qdieiifini
      241 edllrvhthf lkemkealgt pgaanlyqvf ikykerflvy grycsqvesa skhldrvaaa
      301 redvqmklee csqranngrf tlrdllmvpm qrvlkyhlll qelvkhtqea mekenlrlal
      361 damrdlaqcv nevkrdnetl rqitnfqlsi enldqslahy grpkidgelk itsverrskm
      421 dryaflldka llickrrgds ydlkdfvnlh sfqvrddssg drdnkkwshm flliedqgaq
      481 gyelffktre lkkkwmeqfe maisniypen atanghdfqm fsfeettsck acqmllrgtf
      541 yqgyrchrcr asahkeclgr vppcgrhgqd fpgtmkkdkl hrraqdkkrn elglpkmevf
      601 qeyyglpppp gaigpflrln pgdiveltka eaeqnwwegr ntstneigwf pcnrvkpyvh
      661 gppqdlsvhl wyagpmerag aesilanrsd gtflvrqrvk daaefaisik ynvevkhiki
      721 mtaeglyrit ekkafrglte lvefyqqnsl kdcfksldtt lqfpfkepek rtisrpavgs
      781 tkyfgtakar ydfcardrse lslkegdiik ilnkkgqqgw wrgeiygrvg wfpanyveed
      841 yseyc
//